Credit Suisse’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Credit Suisse’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-24,667	Closed	-$339K	–	4329
2019 Q2	$339K	Buy	24,667 +12,898	+110%	+$197K	﹤0.01%	3623
2019 Q1	$203K	Buy	+11,769	New	+$186K	﹤0.01%	3761
2018 Q3	–	Sell	-11,880	Closed	-$154K	–	4094
2018 Q2	$154K	Buy	11,880 +1,664	+16%	+$22.5K	﹤0.01%	3795
2018 Q1	$128K	Buy	+10,216	New	+$124K	﹤0.01%	3766
2017 Q4	–	Sell	-14,898	Closed	-$250K	–	4294
2017 Q3	$250K	Buy	+14,898	New	+$242K	﹤0.01%	3830
2016 Q3	–	Sell	-19,520	Closed	-$175K	–	4325
2016 Q2	$175K	Buy	+19,520	New	+$191K	﹤0.01%	3914
2016 Q1	–	Sell	-18,608	Closed	-$214K	–	4392
2015 Q4	$214K	Buy	+18,608	New	+$230K	﹤0.01%	3854
2015 Q3	–	Sell	-13,234	Closed	-$183K	–	4570
2015 Q2	$183K	Buy	+13,234	New	+$179K	﹤0.01%	4257
2015 Q1	–	Sell	-11,446	Closed	-$155K	–	4658
2014 Q4	$155K	Buy	+11,446	New	+$156K	﹤0.01%	4346
2014 Q3	–	Sell	-16,726	Closed	-$281K	–	4728
2014 Q2	$281K	Buy	+16,726	New	+$301K	﹤0.01%	4157

Other funds holding OXFD

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Credit Suisse's OXFD Position: Q3 2019 in Review

Credit Suisse sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q3 2019, closing a stake of 24,667 shares — an estimated $339K sold.

Credit Suisse first reported a position in OXFD in Q2 2014 and held it in 10 quarters. The position peaked at $339K in Q2 2019. 73 funds tracked by Wall St. Rank hold OXFD as of Q3 2019.

Credit Suisse reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q3 2019 after selling out during the quarter.
Credit Suisse sold 24,667 Oxford Immunotec Global PLC Ordinary Shares shares in Q3 2019, an estimated $339K.
Credit Suisse first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q2 2014 and held it in 10 quarters.
Credit Suisse's Oxford Immunotec Global PLC Ordinary Shares position peaked at $339K in Q2 2019.
73 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q3 2019.

Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.